Targeted antineoplastic therapy in critically ill cancer patients: a multicenter analysis of the iCHOP registry
Anthea Storck(Düsseldorf University Hospital), Michael von Bergwelt‐Baildon(German Cancer Research Center), Matthias Kochanek(Centrum für Integrierte Onkologie), Jan‐Hendrik Naendrup, Randolf Forkert(Johanniter-Krankenhaus Bonn), Alexander Shimabukuro‐Vornhagen(Centrum für Integrierte Onkologie), Jakob Hammersen(Jena University Hospital), Julia Cserna(Medical University of Vienna), Gernot Beutel(Medizinische Hochschule Hannover), Michael Kiehl(Klinikum Frankfurt Höchst), Catherina Lueck(Universität Hamburg), Boris Böll(University Hospital Cologne), Dennis A. Eichenauer(University of Cologne), Nina Buchtele(Medical University of Vienna), Thomas Staudinger(Northwestern University), Asterios Tzalavras(University of Duisburg-Essen), Frank Kroschinsky(University Hospital Carl Gustav Carus), Jorge Garcia Borrega(Düsseldorf University Hospital), Nicole Brueder(Medizinische Hochschule Hannover), Peter Schellongowski(Medical University of Vienna), Tobias Liebregts(Royal Adelaide Hospital), Judit Grans-Sibel(Düsseldorf University Hospital)
Cited by 3
Related Papers
Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies
|The Lancet Infectious Diseases|2013|876
Immune Activation in Patients With Irritable Bowel Syndrome
|Gastroenterology|2007|662
Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS
|Intensive Care Medicine|2013|603
Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy
|Circulation|2020|570
Symptoms of burnout in intensive care unit specialists facing the COVID-19 outbreak
|Annals of Intensive Care|2020|392